.After introducing a stage 3 launch based on beneficial midstage results, iTeos and also GSK are act...
.The FDA needs to be more open and collective to unleash a surge in approvals of rare condition medi...
.It is actually an abnormally occupied Friday for biotech IPOs, along with Zenas BioPharma, MBX and ...
.Atea Pharmaceuticals' antiviral has actually stopped working one more COVID-19 test, yet the biotec...
.Neurocrine Biosciences' mental illness plan pivot has failed. The biotech was unable to replicate t...
.Sanofi has made a late access to the radioligand party, spending one hundred thousand euros ($ 110 ...
.After F2G's 1st try to receive a new training class of antifungal to market was wrecked by the FDA,...
.Moderna has actually sworn to cut R&D costs through $1.1 billion through 2027. The choice to shr...
.Merely 4 months after Sanofi wager $80 million in upfront cash on Key Therapies' losmapimod, the co...
.Cancer business Oncternal Therapies is actually folding all its own clinical trials and laying off ...